Interim Clinical Trial Data: Who Can See What, and When?
Therapeutic Innovation & Regulatory Science · 2025
DOI: 10.1007/s43441-024-00728-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2025. Verfasst von Susan S Ellenberg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. sellenbe@pennmedicine.upenn.edu. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design, Clinical Trials Data Monitoring Committees, Clinical Trials as Topic. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
It has long been a basic principle of randomized clinical trials addressing serious outcomes and/or major public health issues that interim data should be inaccessible to investigators and to industry sponsors, with interim data reviewed on a regular basis by an independent data monitoring committee (DMC). Challenges to this principle may arise when sponsors and/or regulators perceive a need to review interim data while the trial remains ongoing-for example, when a trial is being considered for accelerated approval. In this paper we propose approaches that could minimize the extent of interim data that is made available to others while the trial continues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. sellenbe@pennmedicine.upenn.edu.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Zitieren
APA
Ellenberg, S. S., & Li, Y. (2025). Interim Clinical Trial Data: Who Can See What, and When?. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00728-0
Vancouver
Ellenberg SS, Li Y. Interim Clinical Trial Data: Who Can See What, and When?. Therapeutic Innovation & Regulatory Science. 2025. doi:10.1007/s43441-024-00728-0
BibTeX
@article{Ellenberg2025,
author = {Ellenberg, Susan S and Li, Yimei},
title = {Interim Clinical Trial Data: Who Can See What, and When?},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2025},
doi = {10.1007/s43441-024-00728-0}
}
EUVIMED